Overcoming Temozolomide Resistance in Glioblastoma via Enhanced NAD
BER
MGMT
MMR
MSH6
NAD+
PARG inhibition
PARP activation
TMZ resistance
glioblastoma
temozolomide
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Jul 2022
22 Jul 2022
Historique:
received:
14
06
2022
revised:
17
07
2022
accepted:
20
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is an incurable brain cancer with an average survival of approximately 15 months. Temozolomide (TMZ) is a DNA alkylating agent for the treatment of GBM. However, at least 50% of the patients treated with TMZ show poor response, primarily due to elevated expression of the repair protein O
Identifiants
pubmed: 35892832
pii: cancers14153572
doi: 10.3390/cancers14153572
pmc: PMC9331395
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA148629
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA238061
Pays : United States
Organisme : National Science Foundation
ID : NSF-1841811
Organisme : NIH HHS
ID : ES029518, CA148629, ES014811, ES028949, CA238061, CA236911, AG069740 and ES032522
Pays : United States
Références
Cancer Res. 2019 Sep 1;79(17):4331-4338
pubmed: 31273061
J Neurooncol. 2003 Feb;61(3):203-7
pubmed: 12675312
Sci Adv. 2019 Apr 10;5(4):eaav4340
pubmed: 30989114
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6767-71
pubmed: 16203762
Neuro Oncol. 2014 Oct;16(10):1313-23
pubmed: 24811392
Neuro Oncol. 2009 Jun;11(3):281-91
pubmed: 18952979
Clin Cancer Res. 2009 Jul 15;15(14):4622-9
pubmed: 19584161
Cancer Res. 2006 Apr 15;66(8):3987-91
pubmed: 16618716
Cancer Res. 1994 Feb 1;54(3):649-52
pubmed: 8306326
DNA Repair (Amst). 2020 Sep;93:102930
pubmed: 33087267
Cell Rep. 2014 Sep 25;8(6):1819-1831
pubmed: 25220464
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6443-7
pubmed: 8692834
Br J Cancer. 2019 Oct;121(7):545-555
pubmed: 31413318
Cell Rep. 2021 Nov 2;37(5):109917
pubmed: 34731617
NAR Cancer. 2021 Nov 17;3(4):zcab044
pubmed: 34806016
Cancer Res. 2015 Oct 15;75(20):4416-28
pubmed: 26282173
Front Oncol. 2021 Oct 27;11:745981
pubmed: 34778062
Mol Cancer Res. 2021 Feb;19(2):207-214
pubmed: 33257507
Cancer Res. 2005 Jul 15;65(14):6394-400
pubmed: 16024643
Eur J Cancer. 2005 Dec;41(18):2948-57
pubmed: 16288862
Int J Cancer. 2011 Aug 1;129(3):659-70
pubmed: 21425258
Neuro Oncol. 2020 Jun 9;22(6):875-885
pubmed: 32009149
Nucleic Acids Res. 2011 Jul;39(12):5045-56
pubmed: 21398629
DNA Repair (Amst). 2022 Apr;112:103303
pubmed: 35219626
Carcinogenesis. 1985 Dec;6(12):1823-6
pubmed: 4064256
Nat Rev Cancer. 2016 Jan;16(1):20-33
pubmed: 26678314
Clin Cancer Res. 2004 Jun 1;10(11):3728-36
pubmed: 15173079
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Sci Rep. 2020 Jan 20;10(1):651
pubmed: 31959836
Clin Neurosurg. 2008;55:165-71
pubmed: 19248684
Cancer Res. 2005 Jun 1;65(11):4861-9
pubmed: 15930307
Sci Rep. 2018 Feb 9;8(1):2771
pubmed: 29426857
DNA Repair (Amst). 2007 Jun 1;6(6):695-711
pubmed: 17337257
Mol Cell. 2004 Apr 9;14(1):105-16
pubmed: 15068807
CA Cancer J Clin. 2021 Sep;71(5):381-406
pubmed: 34427324
J Clin Oncol. 2007 Jun 20;25(18):2540-5
pubmed: 17577032
Cancers (Basel). 2021 May 24;13(11):
pubmed: 34073837
Cancer Res. 2018 Dec 15;78(24):6713-6716
pubmed: 30498082
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Mol Med Rep. 2012 Feb;5(2):575-9
pubmed: 22086271
Neuro Oncol. 2011 Apr;13(4):384-92
pubmed: 21317208
Neuro Oncol. 2011 May;13(5):471-86
pubmed: 21377995
DNA Repair (Amst). 2007 Aug 1;6(8):1079-99
pubmed: 17485253
Cancer Res. 2011 Mar 15;71(6):2308-17
pubmed: 21406402
J Biol Chem. 1974 Jun 10;249(11):3475-82
pubmed: 4831224
Front Oncol. 2012 Dec 05;2:186
pubmed: 23227453
J Hematol Oncol. 2018 Feb 27;11(1):32
pubmed: 29486795
Biochem Pharmacol. 2019 Apr;162:98-108
pubmed: 30296409
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Nat Rev Mol Cell Biol. 2006 May;7(5):335-46
pubmed: 16612326
Mol Cell Biol. 2002 Nov;22(22):7831-41
pubmed: 12391152
Cell Rep. 2018 May 15;23(7):2095-2106
pubmed: 29768207
Mol Metab. 2019 Dec;30:192-202
pubmed: 31767171
Nucleic Acids Res. 2013 Aug;41(15):7286-301
pubmed: 23775793
Integr Biol (Camb). 2012 Oct;4(10):1237-55
pubmed: 22892544
Cancer Chemother Pharmacol. 2014 Aug;74(2):257-65
pubmed: 24880570
DNA Repair (Amst). 2016 Feb;38:94-101
pubmed: 26704428
Clin Cancer Res. 2007 Apr 1;13(7):2038-45
pubmed: 17404084
Am J Clin Oncol. 2014 Aug;37(4):369-76
pubmed: 23357973
Cancer Res. 2018 Sep 1;78(17):5060-5071
pubmed: 29976574
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Cancer Discov. 2020 Nov;10(11):1672-1689
pubmed: 32606138